₹ 425.05
-0.25 (-0.06%)
C
Cohance Lifesciences
₹ 425.05
COHANCE Fundamentals
Company Valuation
Market Cap (₹ Cr.)
16,261
PE Ratio
108.60
PB Ratio
4.16
Dividend Yield
1.41%
ROE
14.38%
ROCE
13.36%
Book Value (₹)
102.24
Face Value (₹)
1.00
Analyse COHANCE with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Promoters | 66.41% | 57.49% | 57.49% | 57.49% | 57.49% |
| Domestic Institutional Investors (DII) | 11.40% | 20.82% | 21.57% | 21.79% | 20.09% |
| Foreign Institutional Investors (FII) | 7.23% | 6.51% | 6.02% | 5.59% | 6.50% |
| Public Investors | 6.40% | 6.42% | 6.76% | 7.04% | 7.71% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
COHANCE Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Smallcap
BSE Scrip Code
543064
NSE Scrip Name
COHANCE
ISIN
INE03QK01018



